Furthermore, examination of the distribution of TrkB receptor in DM1 patient brains showed a reduction of TrkB immunoreactivity in the soma region (Fig. 5c), that indicates impaired retrograde transport of DYNLL2-TrkB complex. This evidence concerns the gene NTRK2 and myotonic dystrophy type 1.